Colorectal cancer (CRC) remains one of the most prevalent malignancies and a leading cause of cancer-related mortality worldwide. Beyond tumor-intrinsic ...
Researchers at the Cancer Research Institute and the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, have ...
Omics-driven insights into tumor microenvironment determinants of immunotherapy response in melanoma
Immunotherapy has revolutionized cancer treatment, yet response rates remain highly variable across tumor types and individual patients. Increasing evidence ...
Pro-inflammatory M1 macrophages involved in immune responses accelerate the progression of melanoma through the extracellular ...
Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR) in Lisbon, it is worth highlighting ...
News Medical on MSN
Wnt signaling in fibroblasts drives gastric cancer metastasis to the liver
Researchers at the Cancer Research Institute and the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, have uncovered a critical mechanism that enables gastric cancer to spread to ...
The tumor microenvironment (TME) consists of mediators surrounding a tumor, including diverse cell types, blood vessels, and other cellular components. Certain elements of the TME can benefit patients ...
2hon MSN
New atlas that charts tumor cell diversity could guide personalized therapy for head and neck cancer
Head and neck squamous cell carcinomas (HNSCC) are the seventh-most prevalent form of cancer and are associated with human papilloma virus infection (HPV-positive) or with tobacco and alcohol use (HPV ...
News-Medical.Net on MSN
Study reveals cellular and metabolic landscape of lymph node metastasis in breast cancer
A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast ...
COPENHAGEN, Denmark, March 12, 2026 (GLOBE NEWSWIRE) -- Cbio A/S today announced that it has received regulatory clearance to begin a first-in-human Phase I/IIa clinical trial of novoleucel, the ...
We are what we eat. While both the beneficial and detrimental effects of diet on health are well-documented, from boosting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results